• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Clin Pract . Correlation between chest CT severity score and laboratory indicators in patients with Coronavirus disease 2019 (COVID-19)

tetano

Editor, Senior Moderator
Int J Clin Pract


. 2021 Sep 22;e14907.
doi: 10.1111/ijcp.14907. Online ahead of print.
Correlation between chest CT severity score and laboratory indicators in patients with Coronavirus disease 2019 (COVID-19)


Qunying Lin[SUP] 1 2 [/SUP], Liangning Wu[SUP] 1 [/SUP], Weihua Lin[SUP] 1 2 [/SUP], Linjian Zhu[SUP] 3 [/SUP], Yuxiong Hu[SUP] 1 [/SUP], Guosheng Lin[SUP] 1 [/SUP], Juan Lin[SUP] 1 [/SUP], Haijian Tu[SUP] 4 [/SUP]



Affiliations

Abstract

Objective: The association between computed tomography (CT) and clinical severity of COVID-19 has been demonstrated. However, there are few studies on CT and laboratory indicators in patients in COVID-19. Our aim was to explore the correlation between chest CT images and laboratory indicators of patients with COVID-19 pneumonia.
Methods: This was a retrospective study of patients with COVID-19 diagnosed and treated at the Affiliated Hospital of Putian University between January 24, 2020, and March 06, 2020. The correlation test between first chest CT score and blood cell analysis, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), blood biochemistry, and T lymphocyte subsets (T-Ls) was investigated.
Results: Among the 56 patients, there were 36 (64.3%) males and 20 (35.7%) females. The mean age of the patients was 46.54±15.82 (range, 15-86) years. The CT score in the moderate group was higher than in the mild group (5.06±0.77 vs 1.87±0.88, P<0.05), and higher in the severe group than in the moderate and mild groups (10.71±4.21, P<0.05). In addition, the ESR was significantly higher in the severe group than mild group (32.00 (26.04, 58.24) vs. 11.00 (7.84, 24.70) mm/h, P<0.05). The CD3, CD4, CD8, and CD4/CD8 cells were not different (all P>0.05). The CT scores of all patients correlated positively with CRP, LDH, and ESR (all P<0.01).
Conclusion: The chest CT characteristics of patients with COVID-19 correlated positively with CRP, ESR, and LDH, which may use one of the indicators for the assessment of disease severity.

Keywords: C-reactive protein; COVID-19 diagnosis; computed tomography score; erythrocyte sedimentation rate; laboratory indicators; lactate dehydrogenase; lymphocytes T.
 
Back
Top Bottom